Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q3 2018 13F Holders as of 9/30/2018

Type / Class
Equity / COM STK CL A
Number of holders
164
Total Shares
108M
Shares change
+11M
Total reported value, excl. options
$2.41B
Value change
+$283M
Put/Call ratio
0.26
Number of buys
89
Number of sells
-79
Price
$22.19
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.